SCN1A and peripheral neuropathy: Donepezil might also ameliorate oxaliplatin-induced peripheral neuropathy [136] and confer protection against induced seizures in a mouse model (Scn1a+/-) of Dravet syndrome, an encephalopathy caused by de novo loss-of-function mutations in the SCN1A gene [137].